H22 hepatoma bearing mice treated with DCs and DCs stimulated by ESPs showed a decrease in IL-4, IL-6, or IL-10 compared with their levels in the PBS and ESP groups (p < 0.05). The gene discussed is IL6; the disease is hepatocellular carcinoma.